Didobi commentary in news article – U.S. Developers Swoop In To Help Build Europe’s Budding Life Sciences Industry

Since last January, £2.7B (or $3.4B) has been invested in British biotech as new deals and development pop up in the Golden Triangle of key markets: Oxford, Cambridge and London, according to Savills. That money isn’t going to established players — 52% of developers involved in these projects are classified as new entrants who never used to do life sciences work or are new to the region, Savills Research Director Steven Lang said.

Read more here: https://www.bisnow.com/national/news/life-sciences/european-scientists-have-the-ideas-can-billions-in-biotech-money-get-them-the-labs-113304